Antibody Engineering & Therapeutics, The Annual Meeting of The Antibody Society

Juan Carlos Almagro; Gary L. Gilliland; Felix Breden; Jamie K. Scott; Devin Sok; Matthias Pauthner; Janice M. Reichert; Gustavo Helguera; Raiees Andrabi; Robert Mabry; Mathieu Bléry; James E. Voss; Juha Laurén; Lubna Abuqayyas; Stefan Barghorn; Eshel Ben-Jacob; James E. Crowe; James S. Huston; Stephen Johnston; Eric Krauland; Fridtjof Lund-Johansen; Wayne A. Marasco; Paul W H I Parren; Kai Y. Xu

doi:10.4161/mabs.28421

Antibody Engineering & Therapeutics, The Annual Meeting of The Antibody Society

Juan Carlos Almagro, Gary L. Gilliland, Felix Breden, Jamie K. Scott, Devin Sok, Matthias Pauthner, Janice M. Reichert, Gustavo Helguera, Raiees Andrabi, Robert Mabry, Mathieu Bléry, James E. Voss, Juha Laurén, Lubna Abuqayyas, Stefan Barghorn, Eshel Ben-Jacob, James E. Crowe, James S. Huston, Stephen Johnston, Eric KraulandFridtjof Lund-Johansen, Wayne A. Marasco, Paul W H I Parren, Kai Y. Xu

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The 24th Antibody Engineering & Therapeutics meeting and The Annual Meeting of The Antibody Society brought together a broad range of participants who updated attendees on the latest advances in antibody research and development. Sessions were organized by distinguished members of The Antibody Society and the meeting was seamlessly implemented by IBC Life Sciences. Preconference workshops on 3D modeling and delineation of clonal lineages were featured, and the conference included sessions on a wide range of topics at the forefront of our field that are very important for researchers: a Keynote Session that discussed the role of systems biology in immunobiology, antibody and vaccine engineering; antibody deep sequencing and repertoires; the effects of antibody gene variation and usage on antibody response; directed evolution; knowledge-based antibody and protein design; antibodies in a complex environment; polyreactive antibodies and polyspecificity; the interface between antibody therapy and cellular immunity in cancer; antibodies in cardiometabolic medicine; antibody pharmacokinetics, distribution and off-target toxicity; optimizing antibody formats for immunotherapy; polyclonals, oligoclonals and bispecifics; antibody discovery platforms; and antibody-drug conjugates.

Original language	English (US)
Pages (from-to)	577-618
Number of pages	42
Journal	mAbs
Volume	6
Issue number	3
DOIs	https://doi.org/10.4161/mabs.28421
State	Published - 2014

Keywords

Antibody therapeutics
Antibody-drug conjugate
Bispecific antibodies
Protein scaffolds

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.4161/mabs.28421

Cite this

Almagro, J. C., Gilliland, G. L., Breden, F., Scott, J. K., Sok, D., Pauthner, M., Reichert, J. M., Helguera, G., Andrabi, R., Mabry, R., Bléry, M., Voss, J. E., Laurén, J., Abuqayyas, L., Barghorn, S., Ben-Jacob, E., Crowe, J. E., Huston, J. S., Johnston, S., ... Xu, K. Y. (2014). Antibody Engineering & Therapeutics, The Annual Meeting of The Antibody Society. mAbs, 6(3), 577-618. https://doi.org/10.4161/mabs.28421

Almagro, JC, Gilliland, GL, Breden, F, Scott, JK, Sok, D, Pauthner, M, Reichert, JM, Helguera, G, Andrabi, R, Mabry, R, Bléry, M, Voss, JE, Laurén, J, Abuqayyas, L, Barghorn, S, Ben-Jacob, E, Crowe, JE, Huston, JS, Johnston, S, Krauland, E, Lund-Johansen, F, Marasco, WA, Parren, PWHI & Xu, KY 2014, 'Antibody Engineering & Therapeutics, The Annual Meeting of The Antibody Society', mAbs, vol. 6, no. 3, pp. 577-618. https://doi.org/10.4161/mabs.28421

@article{bb2d788be14140e0969c2bc1d9e55894,

title = "Antibody Engineering & Therapeutics, The Annual Meeting of The Antibody Society",

abstract = "The 24th Antibody Engineering & Therapeutics meeting and The Annual Meeting of The Antibody Society brought together a broad range of participants who updated attendees on the latest advances in antibody research and development. Sessions were organized by distinguished members of The Antibody Society and the meeting was seamlessly implemented by IBC Life Sciences. Preconference workshops on 3D modeling and delineation of clonal lineages were featured, and the conference included sessions on a wide range of topics at the forefront of our field that are very important for researchers: a Keynote Session that discussed the role of systems biology in immunobiology, antibody and vaccine engineering; antibody deep sequencing and repertoires; the effects of antibody gene variation and usage on antibody response; directed evolution; knowledge-based antibody and protein design; antibodies in a complex environment; polyreactive antibodies and polyspecificity; the interface between antibody therapy and cellular immunity in cancer; antibodies in cardiometabolic medicine; antibody pharmacokinetics, distribution and off-target toxicity; optimizing antibody formats for immunotherapy; polyclonals, oligoclonals and bispecifics; antibody discovery platforms; and antibody-drug conjugates.",

keywords = "Antibody therapeutics, Antibody-drug conjugate, Bispecific antibodies, Protein scaffolds",

author = "Almagro, {Juan Carlos} and Gilliland, {Gary L.} and Felix Breden and Scott, {Jamie K.} and Devin Sok and Matthias Pauthner and Reichert, {Janice M.} and Gustavo Helguera and Raiees Andrabi and Robert Mabry and Mathieu Bl{\'e}ry and Voss, {James E.} and Juha Laur{\'e}n and Lubna Abuqayyas and Stefan Barghorn and Eshel Ben-Jacob and Crowe, {James E.} and Huston, {James S.} and Stephen Johnston and Eric Krauland and Fridtjof Lund-Johansen and Marasco, {Wayne A.} and Parren, {Paul W H I} and Xu, {Kai Y.}",

year = "2014",

doi = "10.4161/mabs.28421",

language = "English (US)",

volume = "6",

pages = "577--618",

journal = "mAbs",

issn = "1942-0862",

publisher = "Landes Bioscience",

number = "3",

}

TY - JOUR

T1 - Antibody Engineering & Therapeutics, The Annual Meeting of The Antibody Society

AU - Almagro, Juan Carlos

AU - Gilliland, Gary L.

AU - Breden, Felix

AU - Scott, Jamie K.

AU - Sok, Devin

AU - Pauthner, Matthias

AU - Reichert, Janice M.

AU - Helguera, Gustavo

AU - Andrabi, Raiees

AU - Mabry, Robert

AU - Bléry, Mathieu

AU - Voss, James E.

AU - Laurén, Juha

AU - Abuqayyas, Lubna

AU - Barghorn, Stefan

AU - Ben-Jacob, Eshel

AU - Crowe, James E.

AU - Huston, James S.

AU - Johnston, Stephen

AU - Krauland, Eric

AU - Lund-Johansen, Fridtjof

AU - Marasco, Wayne A.

AU - Parren, Paul W H I

AU - Xu, Kai Y.

PY - 2014

Y1 - 2014

N2 - The 24th Antibody Engineering & Therapeutics meeting and The Annual Meeting of The Antibody Society brought together a broad range of participants who updated attendees on the latest advances in antibody research and development. Sessions were organized by distinguished members of The Antibody Society and the meeting was seamlessly implemented by IBC Life Sciences. Preconference workshops on 3D modeling and delineation of clonal lineages were featured, and the conference included sessions on a wide range of topics at the forefront of our field that are very important for researchers: a Keynote Session that discussed the role of systems biology in immunobiology, antibody and vaccine engineering; antibody deep sequencing and repertoires; the effects of antibody gene variation and usage on antibody response; directed evolution; knowledge-based antibody and protein design; antibodies in a complex environment; polyreactive antibodies and polyspecificity; the interface between antibody therapy and cellular immunity in cancer; antibodies in cardiometabolic medicine; antibody pharmacokinetics, distribution and off-target toxicity; optimizing antibody formats for immunotherapy; polyclonals, oligoclonals and bispecifics; antibody discovery platforms; and antibody-drug conjugates.

AB - The 24th Antibody Engineering & Therapeutics meeting and The Annual Meeting of The Antibody Society brought together a broad range of participants who updated attendees on the latest advances in antibody research and development. Sessions were organized by distinguished members of The Antibody Society and the meeting was seamlessly implemented by IBC Life Sciences. Preconference workshops on 3D modeling and delineation of clonal lineages were featured, and the conference included sessions on a wide range of topics at the forefront of our field that are very important for researchers: a Keynote Session that discussed the role of systems biology in immunobiology, antibody and vaccine engineering; antibody deep sequencing and repertoires; the effects of antibody gene variation and usage on antibody response; directed evolution; knowledge-based antibody and protein design; antibodies in a complex environment; polyreactive antibodies and polyspecificity; the interface between antibody therapy and cellular immunity in cancer; antibodies in cardiometabolic medicine; antibody pharmacokinetics, distribution and off-target toxicity; optimizing antibody formats for immunotherapy; polyclonals, oligoclonals and bispecifics; antibody discovery platforms; and antibody-drug conjugates.

KW - Antibody therapeutics

KW - Antibody-drug conjugate

KW - Bispecific antibodies

KW - Protein scaffolds

UR - http://www.scopus.com/inward/record.url?scp=84899758677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899758677&partnerID=8YFLogxK

U2 - 10.4161/mabs.28421

DO - 10.4161/mabs.28421

M3 - Article

C2 - 24589717

AN - SCOPUS:84899758677

SN - 1942-0862

VL - 6

SP - 577

EP - 618

JO - mAbs

JF - mAbs

IS - 3

ER -

Antibody Engineering & Therapeutics, The Annual Meeting of The Antibody Society

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this